Damon Hostin, Lead, Health System Market Access at Illumina

In this episode we are joined by Damon Hostin, Lead, Health System Market Access at Illumina, in discussing how genomics informs healthcare. Tune in to hear about how knowledge obtained through genomics can support quality, growth and equity goals. This episode is sponsored by Illumina.

Summary

Genomics in Healthcare: How Illumina is Improving Patient Outcomes

Introduction

Genomics is an important tool in modern healthcare that can support quality, growth, and equity goals. To delve deeper into the topic, we spoke with Damon Hostin, Lead of Health System Market Access at Illumina, in our latest episode. In this article, we will discuss key takeaways from the conversation and explore how Illumina is bringing personalized medicine into healthcare.

The Role of Illumina

Illumina is a company that provides technology, services, and data services to improve patient outcomes, control the cost of care, and promote preventative medicine. Their technology has been particularly useful in oncology, rare and undiagnosed diseases, and personalized therapeutic approaches.

Implementing Precision Medicine

In our episode, Damon Hostin spoke about how healthcare leaders can implement precision medicine and integrate it into their institutions. To do this, he discussed several key strategies:

Population Screening

Population screening is an approach that can help identify individuals who are at risk of developing a particular disease or condition. By doing so, healthcare leaders can address and mitigate the risk early on, preventing the development of more serious conditions. Genomics can be helpful in this approach since it allows for more precise identification of at-risk individuals.

Clinical Quality Improvement

Clinical quality improvement involves using data to identify areas for improvement in healthcare delivery. With genomics, healthcare leaders can gain more insight into how certain diseases or conditions develop, and which treatments are most effective. This can result in more targeted and effective care delivery.

Centers of Excellence

Centers of Excellence are institutions that specialize in a particular area of care delivery. With genomics, healthcare leaders can identify areas where centers of excellence can be most effective. For example, genomics can be useful in identifying patients with rare diseases who may not have been properly diagnosed before.

Collaborating Across Specialties

Damon Hostin also stressed the importance of collaboration across different areas of healthcare delivery. Integrating expertise in molecular medicine, genomics, and molecular diagnostics with other areas of healthcare delivery can result in better outcomes for patients. This approach is known as the quadruple aim.

Conclusion

Genomics is an important tool in modern healthcare that can support quality, growth, and equity goals. By partnering with Illumina, healthcare leaders can implement precision medicine strategies that result in more targeted and effective care delivery. Through population screening, clinical quality improvement, centers of excellence, and collaboration across different specialties, healthcare leaders can bring about more personalized care that improves patient outcomes and promotes better health outcomes for all.

 

Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com

 

This episode aired on 12/05/2022 and can be listened here.

 

Subscribe to Beckers Healthcare Podcast here.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.